mitapivat: Clinical Trials

1 trial of mitapivat, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 enrolling by invitation. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Enrolling by invitation 1

Follow mitapivat: new trials by email Literature Review of mitapivat trials Research Report on mitapivat

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Provide Access to Mitapivat for Participants Who Previously Participated in an Agios-Sponsored Mitapivat Study
Mitapivat - Pyruvate Kinase Deficiency, Anemia, Hemolytic
Phase 4Enrolling by invitationAgios Pharmaceuticals, Inc.552023-07-062026-10-28

Conditions studied

Anemia, Hemolytic (1)  ·  Anemia, Sickle Cell (1)  ·  Pyruvate Kinase Deficiency of Red Cells (1)  ·  Thalassemia (1)

Sponsors

Agios Pharmaceuticals, Inc. (1)

Countries

Belgium (1)  ·  Brazil (1)  ·  Canada (1)  ·  France (1)  ·  Israel (1)  ·  Japan (1)  ·  Turkey (Türkiye) (1)  ·  United Kingdom (1)